|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV040462579 |
| 003 |
DE-627 |
| 005 |
20230624073548.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2017 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.earlhumdev.2017.01.010
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2017012000001.pica
|
| 035 |
|
|
|a (DE-627)ELV040462579
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(16)30461-3
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Gien, Jason
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Short-term weight gain velocity in infants with congenital diaphragmatic hernia (CDH)
|
| 264 |
|
1 |
|c 2017
|
| 300 |
|
|
|a 6
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Appropriate post-natal growth remains a mainstay of therapeutic goals for infants with CDH, with the hypothesis that optimizing linear growth will improve survival through functional improvements in pulmonary hypoplasia. However, descriptions of growth and the effect on survival are limited in affected infants.
|
| 700 |
1 |
|
|a Murthy, Karna
|4 oth
|
| 700 |
1 |
|
|a Pallotto, Eugenia K
|4 oth
|
| 700 |
1 |
|
|a Brozanski, Beverly
|4 oth
|
| 700 |
1 |
|
|a Chicoine, Louis
|4 oth
|
| 700 |
1 |
|
|a Zaniletti, Isabella
|4 oth
|
| 700 |
1 |
|
|a Seabrook, Ruth
|4 oth
|
| 700 |
1 |
|
|a Keene, Sarah
|4 oth
|
| 700 |
1 |
|
|a Alapati, Deepthi
|4 oth
|
| 700 |
1 |
|
|a Porta, Nicolas
|4 oth
|
| 700 |
1 |
|
|a Rintoul, Natalie
|4 oth
|
| 700 |
1 |
|
|a Grover, Theresa R.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:106
|g year:2017
|g pages:7-12
|g extent:6
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2017.01.010
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 106
|j 2017
|h 7-12
|g 6
|
| 953 |
|
|
|2 045F
|a 610
|